High-Cost Medicines: Access, Affordability, and Prices

Research output: Chapter in Book/Report/Conference proceedingEntry for encyclopedia/dictionary

Abstract

Access to high-cost medicines is a fundamental human right, but often patients do not have access to these medicines and their use comes at a high price. This chapter explores patients' access to high-cost medicines in different parts of the world, particularly in Europe, Asia-Pacific, and the Americas. The chapter discusses the affordability and strategies to improve access to high-cost medicines. Several studies included in the chapter have demonstrated that there are huge variations in pricing and coverage policies between countries impacting on access.
Original languageEnglish
Title of host publicationEncyclopedia of Pharmacy Practice and Clinical Pharmacy
EditorsZaheer Ud-Din Babar
Pages20-26
Number of pages7
Volume2
EditionFirst
ISBN (Electronic)9780128127360
Publication statusPublished - 20 Jun 2019

Fingerprint

medicine
costs
pricing
human rights
coverage

Cite this

Hasan, S. S., Kow, C. S., & Babar, Z-U-D. (2019). High-Cost Medicines: Access, Affordability, and Prices. In Z. U-D. Babar (Ed.), Encyclopedia of Pharmacy Practice and Clinical Pharmacy (First ed., Vol. 2, pp. 20-26)
Hasan, Syed Shahzad ; Kow, Chia Siang ; Babar, Zaheer-Ud-Din. / High-Cost Medicines: Access, Affordability, and Prices. Encyclopedia of Pharmacy Practice and Clinical Pharmacy. editor / Zaheer Ud-Din Babar. Vol. 2 First. ed. 2019. pp. 20-26
@inbook{5c99dd5f88e149909405e7e05fea7a7c,
title = "High-Cost Medicines: Access, Affordability, and Prices",
abstract = "Access to high-cost medicines is a fundamental human right, but often patients do not have access to these medicines and their use comes at a high price. This chapter explores patients' access to high-cost medicines in different parts of the world, particularly in Europe, Asia-Pacific, and the Americas. The chapter discusses the affordability and strategies to improve access to high-cost medicines. Several studies included in the chapter have demonstrated that there are huge variations in pricing and coverage policies between countries impacting on access.",
author = "Hasan, {Syed Shahzad} and Kow, {Chia Siang} and Zaheer-Ud-Din Babar",
year = "2019",
month = "6",
day = "20",
language = "English",
isbn = "9780128127353",
volume = "2",
pages = "20--26",
editor = "Babar, {Zaheer Ud-Din}",
booktitle = "Encyclopedia of Pharmacy Practice and Clinical Pharmacy",
edition = "First",

}

Hasan, SS, Kow, CS & Babar, Z-U-D 2019, High-Cost Medicines: Access, Affordability, and Prices. in ZU-D Babar (ed.), Encyclopedia of Pharmacy Practice and Clinical Pharmacy. First edn, vol. 2, pp. 20-26.

High-Cost Medicines: Access, Affordability, and Prices. / Hasan, Syed Shahzad; Kow, Chia Siang; Babar, Zaheer-Ud-Din.

Encyclopedia of Pharmacy Practice and Clinical Pharmacy. ed. / Zaheer Ud-Din Babar. Vol. 2 First. ed. 2019. p. 20-26.

Research output: Chapter in Book/Report/Conference proceedingEntry for encyclopedia/dictionary

TY - CHAP

T1 - High-Cost Medicines: Access, Affordability, and Prices

AU - Hasan, Syed Shahzad

AU - Kow, Chia Siang

AU - Babar, Zaheer-Ud-Din

PY - 2019/6/20

Y1 - 2019/6/20

N2 - Access to high-cost medicines is a fundamental human right, but often patients do not have access to these medicines and their use comes at a high price. This chapter explores patients' access to high-cost medicines in different parts of the world, particularly in Europe, Asia-Pacific, and the Americas. The chapter discusses the affordability and strategies to improve access to high-cost medicines. Several studies included in the chapter have demonstrated that there are huge variations in pricing and coverage policies between countries impacting on access.

AB - Access to high-cost medicines is a fundamental human right, but often patients do not have access to these medicines and their use comes at a high price. This chapter explores patients' access to high-cost medicines in different parts of the world, particularly in Europe, Asia-Pacific, and the Americas. The chapter discusses the affordability and strategies to improve access to high-cost medicines. Several studies included in the chapter have demonstrated that there are huge variations in pricing and coverage policies between countries impacting on access.

UR - https://www.elsevier.com/books/encyclopedia-of-pharmacy-practice-and-clinical-pharmacy/babar/978-0-12-812735-3

M3 - Entry for encyclopedia/dictionary

SN - 9780128127353

VL - 2

SP - 20

EP - 26

BT - Encyclopedia of Pharmacy Practice and Clinical Pharmacy

A2 - Babar, Zaheer Ud-Din

ER -

Hasan SS, Kow CS, Babar Z-U-D. High-Cost Medicines: Access, Affordability, and Prices. In Babar ZU-D, editor, Encyclopedia of Pharmacy Practice and Clinical Pharmacy. First ed. Vol. 2. 2019. p. 20-26